secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLARGO, INC. (BLGO)
CIK:        0000880242
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001437749-25-021276
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLargo shareholders approve reverse split authorization; board has no immediate plans
--------------------------------------------------------------------------------

- All seven director nominees elected, including Dennis Calvert, Kenneth Code, Linda Park.
- Advisory say-on-pay passed with 54.7% of votes present (103.9M for, 7.9M against).
- Ratification of Hacker Johnson & Smith as auditor approved with 99.3% for.
- Reverse stock split authorized (51.8% of outstanding shares) but board has no immediate plans to implement.
- CEO states reverse split would only be used if needed to meet minimum price for Nasdaq/NYSE uplisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/880242/000143774925021276/0001437749-25-021276-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/880242/000143774925021276/blgo20250624_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-021276

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer